CCR2 and metabolic dysfunction-associated steatotic liver disease: In agreement with these observations, CCR2 expression in monocytes was significantly lower in NAFLD patients, compared to control subjects [70], which was perhaps the consequence of imbalances between Mon1 and Mon3 fractions, as previously described [73].